Pharma · Public company · Thousand Oaks, CA, US
Amgen Inc
Ticker AMGN · SEC CIK 0000318154
Track this companyFree. Adds Amgen Inc to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline23
- AutoinjectorPhase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- DurvalumabPhase 3 · Extensive-Stage Small-Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- InebilizumabPhase 3 · Autoimmune HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- Maridebart cafraglutidePhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- Maridebart cafraglutidePhase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- Maridebart cafraglutidePhase 3 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- Maridebart CafraglutidePhase 3 · Obesity or OverweightClinicalTrials.gov · fetched Nov 12, 2026
- Maridebart CafraglutidePhase 3 · Atherosclerotic Cardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OlpasiranPhase 3 · Atherosclerotic Cardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 3 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- TarlatamabPhase 3 · Extensive-Stage Small-Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- InebilizumabPhase 2 · Generalized Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- AMG 691Phase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- AMG 691Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- CRS Mitigation StrategiesPhase 1 · Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TarlatamabPhase 1 · Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- XaluritamigPhase 1 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- EvolocumabCardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Routine Lipid ManagementCardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- UPLIZNANeuromyelitis Optica Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During PregnancyRECRUITING · started Jan 15, 2027ClinicalTrials.gov NCT05909761 · fetched Nov 12, 2026
- A Trial of Inebilizumab in Participants With Autoimmune HepatitisPHASE3 · RECRUITING · started Dec 18, 2026ClinicalTrials.gov NCT07598825 · fetched Nov 12, 2026
- A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaPHASE1_PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07313852 · fetched Nov 12, 2026
- Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)PHASE1 · RECRUITING · started Nov 13, 2026ClinicalTrials.gov NCT07908316 · fetched Nov 12, 2026
- Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 DiabetesPHASE3 · RECRUITING · started Oct 16, 2026ClinicalTrials.gov NCT07866066 · fetched Nov 12, 2026
- Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightPHASE3 · RECRUITING · started Oct 15, 2026ClinicalTrials.gov NCT07871409 · fetched Nov 12, 2026
- Improving Implementation of Guideline-Recommended LDL-C Management in High-Risk Cardiovascular PatientsNOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07883564 · fetched Nov 12, 2026
- A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese VolunteersPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 7, 2026ClinicalTrials.gov NCT07745907 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)PHASE2 · RECRUITING · started Jul 21, 2026ClinicalTrials.gov NCT06987539 · fetched Nov 12, 2026
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)PHASE3 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07575399 · fetched Nov 12, 2026
- Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)PHASE1 · RECRUITING · started Apr 8, 2026ClinicalTrials.gov NCT07297979 · fetched Nov 12, 2026
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 25, 2025ClinicalTrials.gov NCT07037433 · fetched Nov 12, 2026
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPHASE3 · RECRUITING · started Jun 25, 2025ClinicalTrials.gov NCT07037459 · fetched Nov 12, 2026
- A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 16, 2024ClinicalTrials.gov NCT06637371 · fetched Nov 12, 2026
- Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and DurvalumabPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 5, 2024ClinicalTrials.gov NCT06211036 · fetched Nov 12, 2026
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)PHASE3 · RECRUITING · started Nov 16, 2023ClinicalTrials.gov NCT05920356 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPHASE3 · RECRUITING · started Aug 24, 2023ClinicalTrials.gov NCT06023589 · fetched Nov 12, 2026
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes TrialPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 14, 2022ClinicalTrials.gov NCT05581303 · fetched Nov 12, 2026
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 10, 2022ClinicalTrials.gov NCT05583227 · fetched Nov 12, 2026
- EVOLVE-MI: EVOLocumab Very Early After Myocardial InfarctionPHASE4 · ACTIVE_NOT_RECRUITING · started Oct 26, 2022ClinicalTrials.gov NCT05284747 · fetched Nov 12, 2026
- A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C MutationPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 30, 2022ClinicalTrials.gov NCT05118854 · fetched Nov 12, 2026
- Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple MyelomaPHASE1_PHASE2 · RECRUITING · started May 19, 2021ClinicalTrials.gov NCT04822337 · fetched Nov 12, 2026
- Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)PHASE1 · ACTIVE_NOT_RECRUITING · started Dec 26, 2017ClinicalTrials.gov NCT03319940 · fetched Nov 12, 2026
- Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaPHASE2 · RECRUITING · started Nov 29, 2017ClinicalTrials.gov NCT03263572 · fetched Nov 12, 2026
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission MaintenancePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 5, 2017ClinicalTrials.gov NCT03114865 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 19, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 19, 2026 · fetched Nov 12, 2026